Originator Organization Asgard Therapeutics ABStartup |
Active Organization- |
Inactive Organization Asgard Therapeutics ABStartup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | SE | Asgard Therapeutics ABStartup | 22 Sep 2021 |